Precision Immunotherapy and Novel Target Discovery in Hematological Malignancy

4,072
Total downloads
13k
Total views and downloads

Participate in this topic

Articles

ORIGINAL RESEARCH

Published on 17 Apr 2025

Multiplex immunophenotyping of human acute myeloid leukemia patients revealed single -cell heterogeneity with special attention on therapy sensitive and therapy resistant subpopulations

Nikolett Gémes
Benedek Rónaszéki
Szabolcs Modok
Zita Borbényi
Imre Földesi
Éva Trucza
Blanka Godza
Zsuzsanna László
Balázs Csernus
5 more
Gábor J. Szebeni

doi 10.3389/fimmu.2025.1563386

289 views

REVIEW

Published on 07 Apr 2025

Mechanisms of HDACs in cancer development

Ying Zhang
Haotian Wang
Zhumei Zhan
Lin Gan
Out Bai

doi 10.3389/fimmu.2025.1529239

493 views

REVIEW

Published on 01 Apr 2025

In the era of targeted therapy and immunotherapy: advances in the treatment of large B-cell lymphoma of immune-privileged sites

Haotian Wang
Ying Zhang
Xin Wan
Zhaoxia Li
Ou Bai

doi 10.3389/fimmu.2025.1547377

425 views

ORIGINAL RESEARCH

Published on 31 Mar 2025

Impact of single nucleotide polymorphisms of immunomodulatory factors on treatment response and prognosis in acute myeloid leukemia

Mingying Li
Tao Sun
Mengyuan Chang
Tingting Liu
Lei Feng
Di Zhang
Yuyan Wu
Yuechan Ma
Huixian Ma
2 more
Jingjing Ye

doi 10.3389/fimmu.2025.1571332

468 views

ORIGINAL RESEARCH

Published on 25 Feb 2025

Raman spectroscopy and bioinformatics-based identification of key genes and pathways capable of distinguishing between diffuse large B cell lymphoma and chronic lymphocytic leukemia

Haoyue Liang
Zhijie Cao
Yansong Ren
Yihan Li
Haoyu Wang
Fanfan Sun
Mei Xue
Guoqing Zhu
Yuan Zhou

doi 10.3389/fimmu.2025.1516946

658 views

ORIGINAL RESEARCH

Published on 20 Feb 2025

Aclacinomycin enhances the killing effect of allogeneic NK cells on acute myeloid leukemia cells by inducing immunogenic cell death

Yongbin Ye
Ning Liu
Yunxin Zeng
Ziwen Guo
Xiaobo Wang
Xiaojun Xu

doi 10.3389/fimmu.2025.1521939

549 views

CASE REPORT

Published on 14 Jan 2025

Case report: The case of T-cell acute lymphoblastic leukemia treated with chemotherapy followed by anti-CD7 CAR-T cells using retroviral vector

Huanhuan Zhou
Wenxiang Zhu
Qihong Ma
Ning Liu
Mengdi Jin
Yaru Feng
Lijun Zhao
Rui Sun
Rongyou Li
4 more
Zhi Guo

doi 10.3389/fimmu.2024.1519055

1,356 views

ORIGINAL RESEARCH

Published on 13 Jan 2025

In vitro functional validation of anti-CD19 chimeric antigen receptor T cells expressing lysine-specific demethylase 1 short hairpin RNA for the treatment of diffuse large B cell lymphoma

Zhi Guo
Mingxin He
Ning Liu
Yiqing Yang
Rui Sun
Jianxun Wang
Qiang Wang

doi 10.3389/fimmu.2024.1521778

1,296 views

ORIGINAL RESEARCH

Published on 10 Jan 2025

Identification of hub genes and immune-related pathways in acute myeloid leukemia: insights from bioinformatics and experimental validation

Mingliang Shan
Li Xu
Wenzhe Yang
Shiguo Liu
Zhaoqing Cui

doi 10.3389/fimmu.2024.1511824

1,052 views

REVIEW

Published on 04 Dec 2024

Siglec15 in blood system diseases: from bench to bedside

Yujia Fan
Liangliang Sun
Juan He
Yuetong Chen
Hongli Ma
Haitao Ding

doi 10.3389/fimmu.2024.1490505

1,201 views

CASE REPORT

Published on 30 Oct 2024

Primary seminal vesicle diffuse large B-cell lymphoma: a case report and review of the literatures

Youli Li
Sufen Cao
Fangfang Lv
Guang-Liang Chen

doi 10.3389/fimmu.2024.1461090

1,156 views
1 citation

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

13kTopic views
8,507Article views
4,072Article downloads

View impact

Articles

Multiplex immunophenotyping of human acute myeloid leukemia patients revealed single -cell heterogeneity with special attention on therapy sensitive and therapy resistant subpopulations

Mechanisms of HDACs in cancer development

In the era of targeted therapy and immunotherapy: advances in the treatment of large B-cell lymphoma of immune-privileged sites

Impact of single nucleotide polymorphisms of immunomodulatory factors on treatment response and prognosis in acute myeloid leukemia

Raman spectroscopy and bioinformatics-based identification of key genes and pathways capable of distinguishing between diffuse large B cell lymphoma and chronic lymphocytic leukemia

Aclacinomycin enhances the killing effect of allogeneic NK cells on acute myeloid leukemia cells by inducing immunogenic cell death

Case report: The case of T-cell acute lymphoblastic leukemia treated with chemotherapy followed by anti-CD7 CAR-T cells using retroviral vector

In vitro functional validation of anti-CD19 chimeric antigen receptor T cells expressing lysine-specific demethylase 1 short hairpin RNA for the treatment of diffuse large B cell lymphoma

Identification of hub genes and immune-related pathways in acute myeloid leukemia: insights from bioinformatics and experimental validation

Siglec15 in blood system diseases: from bench to bedside

Primary seminal vesicle diffuse large B-cell lymphoma: a case report and review of the literatures

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology

Cancer Immunity and Immunotherapy